Nuwellis Inc (NUWE)

$3.22 +0.42 (15.00%)
Market Cap 215,000.00
Revenue (ttm) 8.27M
Net Income (ttm) -17.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -211.85%
Debt to Equity Ratio 0.00
Volume 179,600
Avg Vol 118,520
Day's Range N/A - N/A
Shares Out 77,000.00
Stochastic %K 64%
Beta 0.29
Analysts Strong Buy
Price Target $11.00

Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. wa...

Industry: Medical Devices
Sector: Healthcare
Phone: 952 345 4200
Address:
12988 Valley View Road, Eden Prairie, United States
AZOZ
AZOZ Jul. 15 at 1:43 AM
$NUWE Granted U.S. Patent 🛰️
0 · Reply
sujeto
sujeto Jul. 14 at 10:57 PM
$NUWE finally?
0 · Reply
The_Gambl3r
The_Gambl3r Jul. 14 at 10:50 PM
$NUWE
0 · Reply
pennysqueezepro
pennysqueezepro Jul. 14 at 9:31 PM
$NUWE 3.50 BREAK COMING!!!👀
0 · Reply
K55555
K55555 Jul. 14 at 8:37 PM
$NUWE shorting is ok. But risky.
0 · Reply
PhilipBio
PhilipBio Jul. 14 at 8:27 PM
$NUWE fly!
0 · Reply
pennysqueezepro
pennysqueezepro Jul. 14 at 8:25 PM
$NUWE TOUCH 4.96 AREA!!!
0 · Reply
K55555
K55555 Jul. 14 at 8:12 PM
$NUWE hahaaaaaa. Get ready folks. PUSH!
0 · Reply
pennysqueezepro
pennysqueezepro Jul. 14 at 8:09 PM
$NUWE
0 · Reply
PhilipBio
PhilipBio Jul. 14 at 8:07 PM
$NUWE ready for AH? Moving
0 · Reply
Latest News on NUWE
Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026

Jul 7, 2026, 8:00 AM EDT - 7 days ago

Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026

Nuwellis Proxy statement: Proxy filing

Jul 7, 2026, 8:00 AM EDT - 7 days ago

Nuwellis Proxy statement: Proxy filing

Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)

Jun 26, 2026, 8:00 AM EDT - 18 days ago

Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)

Nuwellis Proxy statement: Proxy filing

Jun 26, 2026, 8:00 AM EDT - 18 days ago

Nuwellis Proxy statement: Proxy filing

Nuwellis Inc trading halted, news pending

2026-06-25T23:50:12.000Z - 19 days ago

Nuwellis Inc trading halted, news pending

Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations

Jun 25, 2026, 8:30 AM EDT - 19 days ago

Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

Jun 24, 2026, 8:30 AM EDT - 20 days ago

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

Nuwellis highlights clinical utility of its Aquadex SmartFlow system

2026-06-18T12:51:14.000Z - 26 days ago

Nuwellis highlights clinical utility of its Aquadex SmartFlow system

Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit

Jun 18, 2026, 8:30 AM EDT - 26 days ago

Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit

Nuwellis CEO transition to transition out of role, Mike McCormick to succeed

2026-06-16T12:50:42.000Z - 4 weeks ago

Nuwellis CEO transition to transition out of role, Mike McCormick to succeed

Nuwellis Appoints Mike McCormick as Chief Executive Officer

Jun 16, 2026, 8:30 AM EDT - 4 weeks ago

Nuwellis Appoints Mike McCormick as Chief Executive Officer

Nuwellis expands collaboration with South Carolina healthcare system

2026-06-10T12:50:10.000Z - 4 weeks ago

Nuwellis expands collaboration with South Carolina healthcare system

Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children's Hospitals

Jun 10, 2026, 8:30 AM EDT - 4 weeks ago

Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children's Hospitals

Nuwellis Announces Closing of $6.0 Million Registered Public Offering

Jun 8, 2026, 9:46 PM EDT - 5 weeks ago

Nuwellis Announces Closing of $6.0 Million Registered Public Offering

Nuwellis 20M share secondary priced at 30c

2026-06-05T12:56:35.000Z - 5 weeks ago

Nuwellis 20M share secondary priced at 30c

Nuwellis Announces Pricing of $6 Million Public Offering

Jun 5, 2026, 8:30 AM EDT - 5 weeks ago

Nuwellis Announces Pricing of $6 Million Public Offering

Nuwellis Registration statement: Registration filing

Jun 4, 2026, 8:00 AM EDT - 5 weeks ago

Nuwellis Registration statement: Registration filing

Nuwellis Slides: Investor presentation

Jun 2, 2026, 7:00 AM EDT - 6 weeks ago

Nuwellis Slides: Investor presentation

Nuwellis Registration statement: Registration filing

May 29, 2026, 8:00 AM EDT - 6 weeks ago

Nuwellis Registration statement: Registration filing

Nuwellis files to sell 4.85M shares of common stock, warrants

2026-05-22T21:15:44.000Z - 7 weeks ago

Nuwellis files to sell 4.85M shares of common stock, warrants

Nuwellis Registration statement: Registration filing

May 22, 2026, 8:00 AM EDT - 7 weeks ago

Nuwellis Registration statement: Registration filing

Nuwellis completes Aquadex SmartFlow System pre-submission meeting with the FDA

2026-05-14T14:09:24.000Z - 2 months ago

Nuwellis completes Aquadex SmartFlow System pre-submission meeting with the FDA

Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label

May 14, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label

Nuwellis Earnings Call Transcript: Q1 2026

May 12, 2026, 9:00 AM EDT - 2 months ago

Nuwellis Earnings Call Transcript: Q1 2026

Nuwellis Earnings release: Q1 2026

May 12, 2026, 9:00 AM EDT - 2 months ago

Nuwellis Earnings release: Q1 2026

Nuwellis Quarterly report: Q1 2026

May 12, 2026, 9:00 AM EDT - 2 months ago

Nuwellis Quarterly report: Q1 2026

Nuwellis, Inc. Announces First Quarter 2026 Financial Results

May 12, 2026, 8:00 AM EDT - 2 months ago

Nuwellis, Inc. Announces First Quarter 2026 Financial Results

Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026

May 5, 2026, 8:00 AM EDT - 2 months ago

Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026

Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting

Apr 29, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting

Nuwellis gets notice of allowance from USPTO for lumen midline catheter

2026-04-28T13:19:54.000Z - 2 months ago

Nuwellis gets notice of allowance from USPTO for lumen midline catheter

Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology

Apr 28, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology

Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat

Apr 23, 2026, 8:30 AM EDT - 2 months ago

Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat

Nuwellis Announces Aquadex Software Update

Apr 21, 2026, 8:30 AM EDT - 3 months ago

Nuwellis Announces Aquadex Software Update

Nuwellis announces return of three former team members

2026-04-16T12:51:56.000Z - 3 months ago

Nuwellis announces return of three former team members

Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum

Apr 16, 2026, 8:30 AM EDT - 3 months ago

Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum

Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services

Apr 9, 2026, 8:30 AM EDT - 3 months ago

Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services

Nuwellis expands commercial footprint with new South Texas territory

2026-04-07T13:45:21.000Z - 3 months ago

Nuwellis expands commercial footprint with new South Texas territory

Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory

Apr 7, 2026, 8:30 AM EDT - 3 months ago

Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory

Nuwellis Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Nuwellis Proxy statement: Proxy filing

Nuwellis Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 3 months ago

Nuwellis Proxy statement: Proxy filing

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

Mar 31, 2026, 8:30 AM EDT - 3 months ago

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

Nuwellis completes acquisition of Rendiatech

2026-03-17T12:27:39.000Z - 4 months ago

Nuwellis completes acquisition of Rendiatech

Nuwellis Completes Acquisition of Rendiatech

Mar 17, 2026, 8:00 AM EDT - 4 months ago

Nuwellis Completes Acquisition of Rendiatech

Nuwellis Earnings Call Transcript: Q4 2025

Mar 10, 2026, 9:00 AM EDT - 4 months ago

Nuwellis Earnings Call Transcript: Q4 2025

Nuwellis Earnings release: Q4 2025

Mar 10, 2026, 9:00 AM EDT - 4 months ago

Nuwellis Earnings release: Q4 2025

Nuwellis Annual report: Q4 2025

Mar 10, 2026, 9:00 AM EDT - 4 months ago

Nuwellis Annual report: Q4 2025

Nuwellis reports Q4 EPS ($1.50) vs ($18.30) last year

2026-03-10T12:21:07.000Z - 4 months ago

Nuwellis reports Q4 EPS ($1.50) vs ($18.30) last year

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

Mar 10, 2026, 8:15 AM EDT - 4 months ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

Nuwellis appoints Goldstein as Director of Clinical Strategy

2026-03-05T13:26:40.000Z - 4 months ago

Nuwellis appoints Goldstein as Director of Clinical Strategy

Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

Mar 5, 2026, 8:00 AM EST - 4 months ago

Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

Nuwellis appoints McDonald, Emerson to board of directors

2026-02-26T13:12:57.000Z - 4 months ago

Nuwellis appoints McDonald, Emerson to board of directors

Nuwellis Appoints David A. McDonald and Martin J.

Feb 26, 2026, 8:00 AM EST - 4 months ago

Nuwellis Appoints David A. McDonald and Martin J.

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

Feb 24, 2026, 8:00 AM EST - 5 months ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

Nuwellis Slides: Investor presentation

Feb 17, 2026, 6:00 AM EST - 5 months ago

Nuwellis Slides: Investor presentation

Nuwellis Registration statement: Registration Filing

Feb 4, 2026, 7:00 AM EST - 5 months ago

Nuwellis Registration statement: Registration Filing

Nuwellis files to sell 4.28M shares of common stock for holders

2026-02-04T11:11:26.000Z - 5 months ago

Nuwellis files to sell 4.28M shares of common stock for holders

Nuwellis appoints Schultz as Chief Financial Officer

2026-01-30T13:25:28.000Z - 5 months ago

Nuwellis appoints Schultz as Chief Financial Officer

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Jan 30, 2026, 8:00 AM EST - 5 months ago

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Nuwellis announces $5M private placement, warrant inducement transaction

2026-01-29T21:45:37.000Z - 5 months ago

Nuwellis announces $5M private placement, warrant inducement transaction

Nuwellis to acquire Rendiatech, terms not disclosed

2026-01-29T21:40:34.000Z - 5 months ago

Nuwellis to acquire Rendiatech, terms not disclosed

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

Jan 29, 2026, 4:36 PM EST - 5 months ago

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

Jan 29, 2026, 4:35 PM EST - 5 months ago

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

Here’s Why Nuwellis Stock (NUWE) Rocketed Today

2026-01-27T14:00:45.000Z - 6 months ago

Here’s Why Nuwellis Stock (NUWE) Rocketed Today

Nuwellis Announces Changes to Board of Directors

Jan 23, 2026, 4:40 PM EST - 6 months ago

Nuwellis Announces Changes to Board of Directors

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Jan 6, 2026, 8:15 AM EST - 6 months ago

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Dec 9, 2025, 8:15 AM EST - 7 months ago

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Dec 4, 2025, 8:15 AM EST - 7 months ago

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Nuwellis Earnings Call Transcript: Q3 2025

Nov 12, 2025, 9:00 AM EST - 8 months ago

Nuwellis Earnings Call Transcript: Q3 2025

Nuwellis Quarterly report: Q3 2025

Nov 12, 2025, 9:00 AM EST - 8 months ago

Nuwellis Quarterly report: Q3 2025

Nuwellis Earnings release: Q3 2025

Nov 12, 2025, 9:00 AM EST - 8 months ago

Nuwellis Earnings release: Q3 2025

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nov 12, 2025, 8:15 AM EST - 8 months ago

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Nov 10, 2025, 9:00 AM EST - 8 months ago

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Oct 23, 2025, 9:00 AM EDT - 9 months ago

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Sep 30, 2025, 8:45 AM EDT - 10 months ago

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Sep 18, 2025, 9:00 AM EDT - 10 months ago

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Sep 17, 2025, 10:16 AM EDT - 10 months ago

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Sep 9, 2025, 9:00 AM EDT - 11 months ago

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Sep 4, 2025, 8:15 AM EDT - 11 months ago

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Aug 21, 2025, 8:15 AM EDT - 11 months ago

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Aug 19, 2025, 8:15 AM EDT - 11 months ago

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 15, 2025, 8:15 AM EDT - 11 months ago

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Nuwellis Earnings Call Transcript: Q2 2025

Aug 14, 2025, 9:00 AM EDT - 11 months ago

Nuwellis Earnings Call Transcript: Q2 2025

Nuwellis Quarterly report: Q2 2025

Aug 14, 2025, 9:00 AM EDT - 11 months ago

Nuwellis Quarterly report: Q2 2025

Nuwellis Earnings release: Q2 2025

Aug 14, 2025, 9:00 AM EDT - 11 months ago

Nuwellis Earnings release: Q2 2025

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 14, 2025, 8:15 AM EDT - 11 months ago

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Aug 7, 2025, 8:15 AM EDT - 1 year ago

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Aug 6, 2025, 8:15 AM EDT - 1 year ago

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Aug 5, 2025, 8:15 AM EDT - 1 year ago

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Nuwellis Stockholders Approve All Proposals at Special Meeting

Aug 4, 2025, 5:24 PM EDT - 1 year ago

Nuwellis Stockholders Approve All Proposals at Special Meeting

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 23, 2025, 8:45 AM EDT - 1 year ago

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Jul 23, 2025, 8:15 AM EDT - 1 year ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

AZOZ
AZOZ Jul. 15 at 1:43 AM
$NUWE Granted U.S. Patent 🛰️
0 · Reply
sujeto
sujeto Jul. 14 at 10:57 PM
$NUWE finally?
0 · Reply
The_Gambl3r
The_Gambl3r Jul. 14 at 10:50 PM
$NUWE
0 · Reply
pennysqueezepro
pennysqueezepro Jul. 14 at 9:31 PM
$NUWE 3.50 BREAK COMING!!!👀
0 · Reply
K55555
K55555 Jul. 14 at 8:37 PM
$NUWE shorting is ok. But risky.
0 · Reply
PhilipBio
PhilipBio Jul. 14 at 8:27 PM
$NUWE fly!
0 · Reply
pennysqueezepro
pennysqueezepro Jul. 14 at 8:25 PM
$NUWE TOUCH 4.96 AREA!!!
0 · Reply
K55555
K55555 Jul. 14 at 8:12 PM
$NUWE hahaaaaaa. Get ready folks. PUSH!
0 · Reply
pennysqueezepro
pennysqueezepro Jul. 14 at 8:09 PM
$NUWE
0 · Reply
PhilipBio
PhilipBio Jul. 14 at 8:07 PM
$NUWE ready for AH? Moving
0 · Reply
pennysqueezepro
pennysqueezepro Jul. 14 at 8:06 PM
$NUWE GOOD NEWS OUT!!!👀
1 · Reply
PhilipBio
PhilipBio Jul. 14 at 7:57 PM
$NUWE bought some more! Lets gooo
0 · Reply
PhilipBio
PhilipBio Jul. 14 at 7:54 PM
$NUWE buy now 😎
0 · Reply
PKIT_Sensai
PKIT_Sensai Jul. 14 at 7:51 PM
$NUWE $NXCT Potential parabolic runner Low float stock with a catalyst Recent RS Entered at 3.24$ Hard stp: 3$ @News Ping Nuwellis Granted U.S. Patent No. 12678592 B2 For "DUAL LUMEN CATHETER"
0 · Reply
PhilipBio
PhilipBio Jul. 14 at 7:51 PM
$NUWE launch time
0 · Reply
LuigiV_
LuigiV_ Jul. 14 at 7:45 PM
$NUWE $RETO $IOTR $MTR fluid
0 · Reply
pennysqueezepro
pennysqueezepro Jul. 14 at 7:35 PM
$NUWE 5 BREAK!!!👀
0 · Reply
PhilipBio
PhilipBio Jul. 14 at 7:31 PM
$NUWE lets move to a market cap of 3M and we are at $32,50
1 · Reply
KUMO2026
KUMO2026 Jul. 14 at 7:30 PM
$NUWE swing trade off RS
0 · Reply
ciggycapital
ciggycapital Jul. 14 at 7:29 PM
$NUWE good lawd the 2 hr chart lmaoo 🚬
0 · Reply
ciggycapital
ciggycapital Jul. 14 at 7:28 PM
$NUWE 🚬 🚬
0 · Reply
PhilipBio
PhilipBio Jul. 14 at 7:28 PM
$NUWE bought more! Lets gooo! Broke the 3,20
0 · Reply